Urothelial cancer
1 – 10 of 122
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Molecular Subtypes of Muscle-Invasive Bladder Cancer
(2025) p.279-295
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Clinical Implementation of Urinary Biomarkers for Surveillance of Non-muscle-invasive Bladder Cancer (NMIBC) : Considerations from the European Association of Urology NMIBC Guideline Panel
- Contribution to journal › Debate/Note/Editorial
-
Mark
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma : Summary of the 2025 Update
- Contribution to journal › Debate/Note/Editorial
-
Mark
Swedish national guidelines on urothelial carcinoma : 2024 update on advanced and metastatic disease
- Contribution to journal › Article
-
Mark
The association between animal protein, plant protein, and their substitution with bladder cancer risk : a pooled analysis of 10 cohort studies
- Contribution to journal › Article
-
Mark
Survival patterns after perioperative treatment escalation and cystectomy for synchronous oligometastatic bladder cancer (M1a/M1b) – a population-based series
- Contribution to journal › Article
-
Mark
Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting
- Contribution to journal › Article
-
Mark
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer : A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels
- Contribution to journal › Article
-
Mark
Bladder cancer subtypes exhibit limited plasticity across different microenvironments and in metastases
- Contribution to journal › Article
-
Mark
Pre-treatment metastatic biopsy : a step towards precision oncology for urothelial cancer
- Contribution to journal › Scientific review
